Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Scientific Reports
Leli ZengHui Chao

Abstract

Cisplatin was the first metal-based therapeutic agent approved for the treatment of human cancers, but its clinical activity is greatly limited by tumor drug resistance. This work utilized the parent complex [Ru(phen)2(PIP)](2+) (1) to develop three Ru(II) complexes (2-4) with different positional modifications. These compounds exhibited similar or superior cytotoxicities compared to cisplatin in HeLa, A549 and multidrug-resistant (A549R) tumor cell lines. Complex 4, the most potent member of the series, was highly active against A549R cancer cells (IC50 = 0.8 μM). This complex exhibited 178-fold better activity than cisplatin (IC50 = 142.5 μM) in A549R cells. 3D multicellular A549R tumor spheroids were also used to confirm the high proliferative and cytotoxic activity of complex 4. Complex 4 had the greatest cellular uptake and had a tendency to accumulate in the mitochondria of A549R cells. Further mechanistic studies showed that complex 4 induced A549R cell apoptosis via inhibition of thioredoxin reductase (TrxR), elevated intracellular ROS levels, mitochondrial dysfunction and cell cycle arrest, making it an outstanding candidate for overcoming cisplatin resistance.

References

May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S T SmileyL B Chen
Dec 16, 1994·Science·L H Hartwell, M B Kastan
Feb 25, 2000·The International Journal of Biochemistry & Cell Biology·J M Matés, F M Sánchez-Jiménez
Dec 26, 2001·Chemical Reviews·E R Jamieson, S J Lippard
Aug 21, 2003·Free Radical Biology & Medicine·Leonardo R SilveiraYlva Hellsten
Jun 23, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Viktor Brabec, Olga Nováková
Oct 24, 2006·Seminars in Cancer Biology·Sabine Urig, Katja Becker
Jan 4, 2007·Journal of the American Chemical Society·Cindy A Puckett, Jacqueline K Barton
Aug 9, 2007·Nature Reviews. Molecular Cell Biology·Francesco PampaloniErnst H K Stelzer
Sep 29, 2007·Science·Klaus MüllerFrançois Diederich
Jan 16, 2008·Accounts of Chemical Research·Adam T HoyeValerian E Kagan
Jan 17, 2008·Chemical Society Reviews·Sophie PurserVéronique Gouverneur
Jun 24, 2008·Journal of Medicinal Chemistry·William K Hagmann
Feb 14, 2009·Nature Protocols·Juergen FriedrichLeoni A Kunz-Schughart
Jul 16, 2009·Current Medicinal Chemistry·Giacomo CossaPaola Perego
Sep 25, 2009·Inorganic Chemistry·Paolo G BombenCurtis P Berlinguette
Dec 17, 2009·Journal of Medicinal Chemistry·Sabine H van RijtPeter J Sadler
Nov 1, 2009·Metallomics : Integrated Biometal Science·Aviva LevinaPeter A Lay
Mar 15, 2011·Metallomics : Integrated Biometal Science·Michael GroesslPaul J Dyson
Aug 13, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Ludivine FetzerMichel Pfeffer
Aug 23, 2011·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Jun-Feng KouLiang-Nian Ji
Sep 6, 2011·Oncogene·L GalluzziG Kroemer
Jul 19, 2012·Angewandte Chemie·Chung-Hang LeungDik-Lung Ma
Feb 21, 2013·Chemical Communications : Chem Comm·Alexis C Komor, Jacqueline K Barton
Mar 14, 2013·Metallomics : Integrated Biometal Science·Chen QianHui Chao
Jan 25, 2014·Chemical Reviews·Katja Dralle Mjos, Chris Orvig
Mar 13, 2014·Current Opinion in Chemical Biology·Nafees Muhammad, Zijian Guo
Mar 13, 2014·Angewandte Chemie·Zhe LiuPeter J Sadler
May 16, 2014·Metallomics : Integrated Biometal Science·Zuandi LuoTianfeng Chen
Nov 5, 2014·Accounts of Chemical Research·Dik-Lung MaChung-Hang Leung
Jan 3, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Rishil J KathawalaZhe-Sheng Chen
Feb 28, 2015·Chemical Society Reviews·Fangfei LiF Richard Keene
Mar 15, 2015·Drug Discovery Today·Tariq A BhatDhyan Chandra
Aug 1, 2015·Journal of Medicinal Chemistry·Li-Juan LiuChung-Hang Leung
May 1, 2015·Chemical Science·Cristina MariGilles Gasser

❮ Previous
Next ❯

Citations

Sep 21, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xiao-Yu ZhangZhe-Sheng Chen
Jan 26, 2017·Chemical Communications : Chem Comm·Leli ZengHui Chao
Oct 12, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Francyelli Mello-AndradeElisângela de Paula Silveira-Lacerda
Nov 28, 2017·Chemical Society Reviews·Fergus E PoyntonThorfinnur Gunnlaugsson
Jun 1, 2018·International Journal of Molecular Sciences·Maiara de Souza OliveiraDaniel Pereira Bezerra
Jun 15, 2018·Dalton Transactions : an International Journal of Inorganic Chemistry·Aderonke Ajibola AdeyemoPartha Sarathi Mukherjee
Oct 12, 2018·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Sidhali U ParsekarManjuri Kumar
Apr 25, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Katia M OliveiraRodrigo S Correa
Sep 19, 2017·Chemistry : a European Journal·Vojtech NovohradskyViktor Brabec
Mar 10, 2018·Current Medicinal Chemistry·Andrea Erxleben
Jun 24, 2018·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Deliang KongZhe Liu
Dec 5, 2018·Frontiers in Pharmacology·Ke LinJin-Quan Wang
Aug 23, 2019·Dalton Transactions : an International Journal of Inorganic Chemistry·Mohammad Mehdi HaghdoostAnnie Castonguay
Dec 20, 2018·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Qiao-Yan YiYun-Jun Liu
Feb 26, 2019·Scientific Reports·Subramanian AmbikaMuthuraman Sundararaman
Dec 29, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Anna Jastrząb, Elżbieta Skrzydlewska
Jan 16, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhuo-Xun WuYihang Pan
Jan 27, 2021·Chemical Communications : Chem Comm·Chao GeYong Qian
Dec 24, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Ashaparna MondalPriyankar Paira
Feb 11, 2021·Clinical and Experimental Pharmacology & Physiology·Yuhui ZhaoHuirong Liu
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Francyelli Mello-AndradeElisângela de Paula Silveira-Lacerda
Apr 29, 2021·Inorganic Chemistry·Pran Gobinda NandiAkshai Kumar
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sepideh MirzaeiKwang-Seok Ahn
Jun 6, 2021·Journal of Inorganic Biochemistry·Francisco Rinaldi-NetoDenise Crispim Tavares
Aug 18, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Andreia ValentePetra Heffeter
Dec 21, 2016·Inorganic Chemistry·Aderonke Ajibola AdeyemoPartha Sarathi Mukherjee
Feb 16, 2018·Journal of Medicinal Chemistry·Sreekanth ThotaEliezer J Barreiro
Dec 7, 2021·Rapid Communications in Mass Spectrometry : RCM·Ines Starke, Sylvia Fürstenberg

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
fluorescence-activated cell sorting
reactive
column chromatography
FACS
protein assay

Software Mentioned

FlowJo
RTCA

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis